Climara Pro® (estradiol/levonorgestrel transdermal system)
Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics.
postmenopausal osteoporosis
Menostar® (estradiol transdermal system)
Menostar (estradiol transdermal system) is designed to provide nominal in vivo delivery of 14 mcg of estradiol per day continuously upon application to intact skin. The period of use is 7 days
ATELVIA® (risedronate sodium)
Risedronate has an affinity for hydroxyapatite crystals in bone and acts as an antiresorptive agent. At the cellular level, risedronate inhibits osteoclasts. The osteoclasts adhere normally to the bone surface, but show evidence of reduced active resorption
BONIVA (ibandronate sodium)
BONIVA (ibandronate sodium) is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption. BONIVA is indicated for the treatment and prevention of postmenopausal osteoporosis.